Fadia Tohme-Shaya, PhD, MPH, is a Tenured Professor in Pharmaceutical Outcomes Research at the University of Maryland School of Pharmacy, and in Epidemiology and Preventive Medicine at the University of Maryland School of Medicine. She is also Director of Research at the Center for Innovative Pharmacy Solutions and Associate Director for the Center on Drugs and Public Policy. Prior to that, she worked in health care consulting in Washington, DC, at the Johns Hopkins Bayview Medical Center, the Johns Hopkins Bloomberg School of Public Health, the Health Planning Commission in Paris, France, and at the American University of Beirut, Lebanon.

Dr. Tohme-Shaya has expertise in formulary development and management. She has built research capacity to support all stages of drug development and policy, from pre-clinical trials to post-marketing surveillance. She has experience in developing clinical, economic, policy, decision analysis, and budget impact models. She works with state, commercial, and Medicare plans, to guide drug formulary management, specifically relating to oncology, cardiovascular disease, and COPD. Her extra-mural research is supported by federal, commercial, and foundation grants and contracts.

A member of the Pharmacy and Therapeutics committee at CareFirst BlueCross BlueShield, she also serves on the Editorial Advisory Boards of the Journal of Medical Economics, the Journal of Managed Care Pharmacy, Expert Review in Pharmacoeconomics and Outcomes Research, and P&T. She is a reviewer for and has published in peer-reviewed journals, including Circulation, The Lancet, Health Affairs and Archives of Internal Medicine. She has reviewed over 300 papers for publication in these journals and has published over 200 articles in peer-reviewed science journals. She regularly presents at national and international scientific and policy meetings, with over 250 presentations and posters to date. She has also been an invited speaker at Harvard Medical School, the Johns Hopkins University, the Institute of Medicine, and various other federal, academic, or industry venues. Her current research focuses on the implementation of new Medicare policies, comparative effectiveness, survival analysis, propensity scores modeling, and applications to clinical decision-making and coverage decisions.